Heerlen, NL, 02 Apr 2015 08:16 CEST
Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has finalized the sale of DSM Synres to Standard Investment. The divestment was announced on 17 December 2014.
DSM Synres produces solvent-borne alkyd and acrylic coating resins at its site in Hoek van Holland (Netherlands) for the global coatings, adhesives and graphic arts markets since 1947. DSM Synres realizes sales of approximately €50 million with around 80 employees.
Standard Investment, based in Amsterdam, is a hands-on private equity firm focused on small and medium-sized enterprises in the Netherlands and Belgium. Since its establishment in 2004, the firm has acquired a portfolio of 18 companies.